It has been reported that the deletion of IKKβ in the intestinal cells failed to reduce inflammation but lead to a significant decrease in tumor incidence without affecting the tumor size in colitis‐associated cancer (CAC) mouse model [248]. Here, IKBKB is linked to neoplasm.